The use of Citalopram in an integrated approach to the treatment of eating disorders: An open study

Eating and Weight Disorders

Volumn 4, Issue 4, 1999, Pages 207-210

  Calandra, C ^a   Gulino, V ^a   Inserra, L ^a   Giuffrida, A ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Antidepressants; Citalopram; Eating disorders; Systemic psychotherapy; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM;

ADOLESCENT; ADULT; ANOREXIA NERVOSA; ARTICLE; BODY IMAGE; BODY MASS; BULIMIA; FEMALE; HUMAN; MULTIMODALITY CANCER THERAPY; PERSONALITY TEST; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY;

ADOLESCENT; ADULT; ANOREXIA NERVOSA; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BODY IMAGE; BODY MASS INDEX; BULIMIA; CITALOPRAM; COMBINED MODALITY THERAPY; FEMALE; HUMANS; PERSONALITY INVENTORY; PSYCHOTHERAPY;

EID: 0033288114     PISSN: 11244909     EISSN: 15901262     Source Type: Journal    
DOI: 10.1007/BF03339739     Document Type: Article

References (12)

1. Goldstein D.J., Wilson M.G., Thompson V.L., Potvin J.H., Rampey A.H. Jr.: Long term fluoxetine treatment of bulfmia nervosa. Fluoxetine Bulimia Nervosa Research Group. Br. J. Psychiatry, 166, 660-666, 1995.
2. Stokes P.E., Holtz A.: Fluoxetine tenth anniversary update: the progress continues. Clin. Ther., 19, 1135-1150, 1997.
3. Advokat C, Kutlesic V.: Pharmacotherapy of the eating disorders: a commentary. Neurosci. Biobehav. Rev., 19, 59-66, 1995.
4. Finley P.R.: Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions. Ann. Pharmacother., 28, 1359-1369, 1994.
5. Brambilla F., Draisci A., Peirone A., Brunetta M.: Combined cognitive-behavioral, psychopharmacological and nutritional therapy in eating disorders. 2. Anorexia nervosa binge eating/purging type. Neuropsychobiology, 32, 64-67, 1995.
6. Rissanen A., Naukkarinen H., Virkkunen M., Rawlings R.R., Linnoila M.: Fluoxetine normalizes increased cardiac vagal tone in bulimia nervosa. J. Clin. Psychopharmacol., 18, 26-32, 1998.
7. Fichter M.M., Kruger R., Rief W., Holland R., Dohne J.: Fluvoxamine in prevention of relapse in bulimia nervosa: effects on eating specific psychopathology. J. Clin. 1994 Dec. Psychopharmacol., 16, 9-18, 1996.
8. Fichter MM., Leibl C, Kruger R., Rief W.: Effects of fluvoxamine on depression, anxiety, and other areas of general psychopathology in bulimia nervosa. Pharmacopsychiatry, 30, 85-92, 1997.
9. Cebollada A., Chinchilla A., Vega M. et al: Psychopharmacological treatment of anorexia nervosa. Eur. Neuropsychopharmacol. 11, 273-278, 1996.
10. Calandra C, Gulino V.: Individual psychotherapy by a systemic approach in bulimic patients. Minerva Psichiatr., 40, 47-52, 1999.
11. Garner D.M. et al: Development and validation of a multidimensional Eating Disorder Inventory for anorexia nervosa and bulimia nervosa. Int. J. Eating Disord., 2, 15, 1983.
12. Hawkins R., Clement P.: Development and costruct validation of a self report measure of binge eating tendencies. Addict. Behav., 5, 219, 1980.